FITLIFE BRANDS, INC. 8K

FitLife Brands, Inc. announced first quarter 2026 results showing strong revenue growth driven by the Irwin acquisition but lower gross margins, slightly reduced net income and adjusted EBITDA, supply chain and demand headwinds, and continued debt reduction and Amazon channel expansion.

FitLife Brands, Inc. reported its financial results for the first quarter ended March 31, 2026, highlighting a 59% year-over-year increase in total revenue to $25.3 million driven largely by the acquisition of Irwin, which contributed materially to wholesale sales but at a lower gross margin, resulting in consolidated gross margin compression to 37.6% and a modest decline in net income to $1.7 million and adjusted EBITDA to $3.3 million. The company detailed contrasting performance between its Legacy FitLife brands, which saw a 22% revenue decline due to weaker wholesale sales (notably to GNC) and lower online MRC sales, and Irwin, which generated 80% of its revenue from wholesale, showed strong growth on Amazon despite supply chain–related out-of-stock issues that management estimates reduced Irwin revenue by $1.0–$1.5 million. Management discussed a challenging macro consumer environment, changes in Amazon’s algorithms impacting promotional strategy, ongoing efforts to resolve Irwin supply chain issues, and a continued focus on deleveraging, including $1.5 million of scheduled term loan amortization and a $1.4 million paydown on the revolver, leaving $37.6 million outstanding on the term loan, $4.2 million on the revolver, and net debt of approximately $40.6 million as of quarter-end. They also highlighted sequential monthly revenue improvement, growing Amazon sales for Irwin at an annualized run-rate of about $9.6 million, and new distribution for two MusclePharm SKUs in several hundred Kroger stores beginning in June, while reiterating forward-looking statements about future growth and risk factors.

Filing Facts

CIK

1374328

Ticker

-

Form

8K

Source Type

sec

Accession

0001437749-26-016983

Alert Tier

7